How will new NSAAs impact clinical practice in prostate cancer?
The threat to specialist cancer nurses
Pros and cons of biomarker testing
ICON8: Outcome in progression-free survival for weekly-dose paclitaxel in first-line ovarian cancer
Lung cancer screening in the UK: yes or no?